Company: PSTV
Filing Date: 2025-04-30
Form Type: 10-K/A
Source: 0000950170-25-061028
Chunk: 19

Company: PLUS THERAPEUTICS, INC.
Filing Date: 2025-04-30
Form: 10-K/A
Chunk 19
---
 based exclusively on attainment of our corporate goals, Dr. Hedrick received $336,622, or 110% of his target cash bonus. Based upon the attainment of 110% of the corporate goals, and (i) upon an attainment of seventy-five percent (75%) of his individual goals, our Chief Financial Officer, Mr. Sims, received $125,803, or 101% of his target cash bonus; and (ii) upon an attainment of 100% of his individual goals, our former Chief Medical Officer, Dr. LaFrance, received $161,700, or 105% of his target cash bonus.

Personal Benefits and Perquisites

All of our executives are eligible to participate in our employee benefit plans, including medical, dental, vision, life insurance, short-term and long-term disability insurance, flexible spending accounts and 401(k). These plans are available to all full-time employees. In keeping with our philosophy to provide total compensation that is competitive within our industry, we offer limited personal benefits and perquisites to executive officers. You can find more information on the amounts paid for these perquisites to, or on behalf of, our NEOs in our Summary Compensation Table.

Outstanding Equity Awards at December 31, 2024

The following table sets forth information regarding outstanding equity awards held by our NEOs as of December 31, 2024.

| Name                                  | ​         | ​ | Option        
 Grant Date(1) |      ​ | ​ |      Number of 
     Securities 
     Underlying 
    Unexercised 
    Options (#) 
 Exercisable(3) |     ​ | ​ |           Number of 
          Securities 
          Underlying 
         Unexercised 
            Unearned 
         Options (#) 
 Unexercisable(2)(3) |      ​ | ​ |       Option 
     Exercise 
 Price ($)(3) | ​         | ​ | Option     
 Expiration 
 Date       |
| Marc H. Hedrick, M.D.,                
 President and Chief Executive Officer | ​         | ​ | 1/30/2015     |      ​ | ​ |              3 |     ​ | ​ |                   — |      ​ | ​ |       54,000 | ​         | ​ | 1/30/2025  |
| ​                                     | 1/4/2016  | ​ | ​             |      8 | ​ |              ​ |     — | ​ |                   ​ | 21